Provided by Tiger Fintech (Singapore) Pte. Ltd.

Erasca, Inc.

1.16
-0.0100-0.85%
Post-market: 1.160.00000.00%16:05 EDT
Volume:952.48K
Turnover:1.11M
Market Cap:328.59M
PE:-1.68
High:1.19
Open:1.16
Low:1.12
Close:1.17
Loading ...

AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer

Zacks
·
21 Jan

Down -27.17% in 4 Weeks, Here's Why Erasca (ERAS) Looks Ripe for a Turnaround

Zacks
·
20 Jan

Down -22.89% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS)

Zacks
·
16 Jan

Bank of America Securities Reaffirms Their Buy Rating on Erasca (ERAS)

TIPRANKS
·
15 Jan

Pfizer Meets Goal in Non-Muscle Invasive Bladder Cancer Study

Zacks
·
13 Jan

Erasca Raised to Buy From Neutral by B of A Securities

Dow Jones
·
08 Jan

BofA Securities Upgrades Erasca to Buy From Neutral, Maintains $5 Price Target

MT Newswires Live
·
07 Jan

Erasca Inc : Bofa Global Research Raises to Buy From Neutral

THOMSON REUTERS
·
07 Jan

Erasca upgraded to Buy from Neutral at BofA

TIPRANKS
·
07 Jan

One Erasca Insider Raised Stake By 14% In Previous Year

Simply Wall St.
·
09 Dec 2024

Jefferies Initiates Erasca at Buy With $6 Price Target

MT Newswires Live
·
18 Nov 2024

Erasca Initiated at Buy by Jefferies

Dow Jones
·
18 Nov 2024

Erasca initiated with a Buy at Jefferies

TIPRANKS
·
18 Nov 2024

Erasca (ERAS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks
·
15 Nov 2024

Bank of America Securities Sticks to Its Hold Rating for Erasca (ERAS)

TIPRANKS
·
15 Nov 2024

Erasca, Inc. Reports Strong Progress in Oncology Pipeline

TIPRANKS
·
14 Nov 2024

Erasca Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Nov 2024

Erasca Q3 EPS $(0.11) Beats $(0.18) Estimate

Benzinga
·
13 Nov 2024

BRIEF-Erasca Q3 Basic EPS USD -0.11

Reuters
·
13 Nov 2024

Erasca Q3 Basic EPS USD -0.11

THOMSON REUTERS
·
13 Nov 2024